Research project promoting patient-specific nucleic acid drug development for rare and intractable diseases (N-of-1+ drug development) selected by AMED
Japan’s first N-of-1+ drug development to be implemented through international collaboration with the n-Lorem Foundation in the United States

Led by Associate Professor Hiroya Kuwahara of Department of Neurology and Neurological Science and the Nucleotide and Peptide Drug Discovery (TIDE) Center at the Institute of Science Tokyo, “Advancing personalized nucleic acid therapeutics for rare and intractable diseases” has been selected as a new research project for fiscal year 2026 under the “Research Project for Practical Application of Intractable Diseases” by the Japan Agency for Medical Research and Development (AMED). READ MORE

Dr. Kumiko Ui-Tei appointed Director of the TIDE Center

Message

The Nucleotide and Peptide Drug Discovery Center (TIDE Center) at the Institute of Science Tokyo promotes middle molecule drug discovery, focusing on nucleotide and peptide therapeutics. The Center advances convergence science by integrating specialists from diverse fields such as basic medicine, clinical medicine, structural biology, data science, nucleic acid chemistry, peptide chemistry, polymer engineering, pharmacology, pharmacokinetics, toxicology, and pharmaceutical formulation. READ MORE

Institute of Science Tokyo established following merger of Tokyo Medical and Dental University and Tokyo Institute of Technology

READ MORE